Clinical Trial Update: A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic drug–drug interaction study evaluating sitaxsentan with sildenafil and sitaxsentan with tadalafil in pulmonary arterial hypertension; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)
• Sitaxsentan (sitaxsentan)
• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Pfizer | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: TERMINATED | Results posted: 2012-02-22